Topic Menu
► Topic MenuTopic Editors

Knee Osteoarthritis—How Close are We to Disease Modifying Treatment?
Topic Information
Dear Colleagues,
Osteoarthritis (OA) is a leading cause of disability worldwide. It is characterized by complex pathogenesis and damage to different components of the joint; cartilage, bone and related structures. OA may manifest with different localization but, until now, the approach in different forms of OA is standardized and not adapted to the different pathogenic mechanisms and phenotypes of the disease. At present, there is no approved disease-modifying drug for the treatment of OA. Therapeutic approaches directed towards specific underlying pathogenic process in OA or administration of a drug combination may slow the disease progression. A new personalized approach towards OA patients with different phenotypes, which aims to retard disease progression, i.e., to possess disease-modifying potential, is more than welcome. Knee OA is among the most common disease localizations. In a proportion of cases, knee OA is associated with obesity and metabolic syndrome. Increased risk of OA in obese patients was suggested to be not only a consequence of mechanical overload but also related to the effects of adipokines. The role of adipokines in knee OA remains to be elucidated. Obesity-associated knee OA is suggested to represent a distinct phenotype—the so-called metabolic knee OA. Personalized complex therapeutic strategy should be evaluated both in animal models of the disease and humans in order to approach effective disease-modifying treatment in OA.
Dr. Sevdalina Lambova
Dr. Erik Lubberts
Topic Editors
Keywords
- knee osteoarthritis
- adipokines
- disease-modifying treatment
- mice model of osteoarthritis
- body mass index
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Life
|
3.4 | 6.0 | 2011 | 19.3 Days | CHF 2600 |
![]()
Biomedicines
|
3.9 | 6.8 | 2013 | 17 Days | CHF 2600 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.